Clinical Trials at Stanford CRS
During the past decade, Stanford CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford CRS"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Facet Biotech" with 1 trials as a collaborator and "Immuno-US" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Stanford CRS
According to Clinical.Site data, the most researched conditions in "Stanford CRS" are
"HIV Infections" (4 trials), "Cytomegalovirus Retinitis" (1 trials) and "Peripheral Nervous System Disease" (1 trials). Many other conditions were trialed in "Stanford CRS" in a lesser frequency.
Clinical Trials Intervention Types at Stanford CRS
Most popular intervention types in "Stanford CRS" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Didanosine" (2 trials), "Delavirdine mesylate" (1 trials), "Foscarnet sodium" (1 trials), "Ganciclovir" (1 trials) and "Nerve Growth Factor, Recombinant Human" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford CRS
The vast majority of trials in "Stanford CRS" are
4 trials for "All" genders.
Clinical Trials Status at Stanford CRS
Currently, there are NaN active trials in "Stanford CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Stanford CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford CRS, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".